LynxCare, an AI-powered medical data platform in Belgium, has raised €20 m to expand internationally. MTIP, a Swiss healthtech investor, led the Series A investment, which was joined by Elaia and the company’s early investors Heran Partners, PMV and BTOV.
For some time, hospitals have been digitising and now have access to massive amounts of data to improve scientific research and patient care. However, due to technical challenges, an estimated 90percent of this data is still unutilized.
The Belgian platform, founded in 2015 by Dries Hens and Georges De Feu enables hospitals to gain insights into real-world treatment performance and feed clinical insights for doctors. To improve patient outcomes, the company employs an AI and NLP (Natural Language Processing)
The additional funding will help the platform expand internationally faster. “We are at the forefront of revolution in which actual patients and their data would characterise the course of healthcare, rather than medical practise or scientific convention,” said Georges De Feu, co-founder and CEO of LynxCare.
“The timing is ideal to collaborate with the European health data pioneer and drive forward the actual data plan to enable better care outcomes,” said MTIP’s managing partner, Dr. Christoph Kausch.
PSIH Group, a leading company in clinical intelligence in France, has also joined forces with the Belgian platform. As a result of this agreement, LynxCare’s software is now available to 66 percent of French hospital groups.